GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » Price-to-Owner-Earnings

Mankind Pharma (BOM:543904) Price-to-Owner-Earnings : 50.79 (As of May. 26, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma Price-to-Owner-Earnings?

As of today (2024-05-26), Mankind Pharma's share price is ₹2063.45. Mankind Pharma's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₹40.63. It's Price-to-Owner-Earnings for today is 50.79.


The historical rank and industry rank for Mankind Pharma's Price-to-Owner-Earnings or its related term are showing as below:

BOM:543904' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 51.52   Med: 57.07   Max: 58.29
Current: 51.52

During the past 5 years, the highest Price-to-Owner-Earnings of Mankind Pharma was 58.29. The lowest was 51.52. And the median was 57.07.


BOM:543904's Price-to-Owner-Earnings is ranked worse than
75.78% of 417 companies
in the Drug Manufacturers industry
Industry Median: 27.13 vs BOM:543904: 51.52

As of today (2024-05-26), Mankind Pharma's share price is ₹2063.45. Mankind Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹47.69. Therefore, Mankind Pharma's PE Ratio for today is 43.26.

As of today (2024-05-26), Mankind Pharma's share price is ₹2063.45. Mankind Pharma's EPS without NRI for the trailing twelve months (TTM) ended in was ₹47.69. Therefore, Mankind Pharma's PE Ratio without NRI for today is 43.26.

During the past 5 years, Mankind Pharma's highest PE Ratio without NRI was 53.33. The lowest was 41.35. And the median was 48.82.


Mankind Pharma Price-to-Owner-Earnings Historical Data

The historical data trend for Mankind Pharma's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma Price-to-Owner-Earnings Chart

Mankind Pharma Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
- - - - 56.54

Mankind Pharma Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 56.54

Competitive Comparison of Mankind Pharma's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Mankind Pharma's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mankind Pharma's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mankind Pharma's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Mankind Pharma's Price-to-Owner-Earnings falls into.



Mankind Pharma Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Mankind Pharma's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=2063.45/40.63
=50.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mankind Pharma  (BOM:543904) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Mankind Pharma Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Mankind Pharma (BOM:543904) Business Description

Traded in Other Exchanges
Address
262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020
Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines